Ryzneuta
Efbemalenograstim alfa-vuxw · Acrotech Biopharma Inc
PRESCRIPTION ONLY (USA)Ryzneuta ingredients
| Active ingredient | Strength |
|---|---|
| Efbemalenograstim Alfa | 20 mg/mL |
What Ryzneuta is used for
Ryzneuta is a specialist medicine (leukocyte growth factor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Ryzneuta
- Generic name
- Efbemalenograstim alfa-vuxw
- Made by
- Acrotech Biopharma Inc
- Forms
- Injection
- Given
- Subcutaneous
- Drug class
- Leukocyte Growth Factor
- FDA approval
- Biologic licence (BLA) BLA761134
- On the US market since
- 2023
Official information
- MedlinePlus drug information (search for Efbemalenograstim alfa-vuxw)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Ryzneuta?
Ryzneuta (Efbemalenograstim alfa-vuxw) is a specialist medicine made by Acrotech Biopharma Inc, approved by the US FDA.
What are the ingredients of Ryzneuta?
Ryzneuta contains Efbemalenograstim Alfa (20 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA